FT. MYERS, Fla., Sept. 3 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it will present at the Rodman & Renshaw 11th Annual Healthcare Conference being held from September 9-11, 2009 at the New York Palace Hotel in New York City. The conference will showcase small and microcap public life sciences and biotech companies. Senior executives of attending companies will make presentations to portfolio managers and analysts on their business strategy and outlook. One-on-one meetings with interested parties will also be arranged during the three-day conference.
NeoGenomics is scheduled to present on Thursday, September 10th at 3:40 PM EDT in the Fahnestock Salon on the fifth floor of the hotel. A live audio webcast of the presentation can be accessed at http://www.wsw.com/webcast/rrshq15/ngnm.ob. A PowerPoint presentation and a link to the webcast can also be accessed through the investor relations section of the NeoGenomics website at http://www.neogenomics.org/ at the time of the conference. The webcast will be available for three months.
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org/.
For more news and information on NeoGenomics, please visit http://www.irgnews.com/coi/NGNM where you can find a fact sheet on the company, investor presentations, and more. Interested parties can also access additional investor relations material, including an investment profile and an equity research report, from Hawk Associates at http://www.hawkassociates.com/ or from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/.
NeoGenomics, Inc.
CONTACT: Steven C. Jones, Director of Investor Relations of NeoGenomics,
Inc., +1-239-325-2001, sjones@neogenomics.org; or Ms. Julie Marshall of Hawk
Associates, Inc., +1-305-451-1888, neogenomics@hawkassociates.com; or Investor
Relations, Rachel Colgate, +1-212-825-3210,
rcolgate@investorrelationsgroup.com, or Media Relations, Janet Vasquez,
+1-212-825-3210, jvasquez@investorrelationsgroup.com, both of The Investor
Relations Group
Web Site: http://www.neogenomics.org/
